Investigation of Ki67 biomarker
17 Dec 2012
Investigation of Ki67 biomarker
Effects of obesity in breast cancer patients
The AZURE translational study
Diagnosis of blood cancer after a breast cancer diagnosis
Neratinib shows beneficial effects in the treatment of HER2 mutated breast cancer
Breast cancer genome sequencing identified HER2 mutations as targets for drug treatment
Colon cancer microenvironments preventing invasion and metastasis
RAB5, master regulator of tumour, mesenchymal invasive programmes
Regulation of self-renewal in cancer stem cells
Interplay between pathologies of ovarian cancer and genomics
Benefit of exercise to cancer survivors
The importance of hereditary genes to cancer susceptibility